Surveillance and prognosis of stage T1 superficial bladder tumours. A homogeneous series of 89 cases followed for 1 to 22 years;Surveillance et pronostic des tumeurs superficielles ≪T1≫ de vessie. Une série homogène de 88 cas suivis de 1 à 22 ans

Progres en Urologie

Volumn 11, Issue 3, 2001, Pages 472-477

  Lachand, Alain Tiberius ^a   Texier, Jean ^a   Texier, Philippe ^a  

^a Clinique Sarrette   (France)

Author keywords

Prognosis; Risk factors; Superficial bladder cancer

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; FEMALE; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TIME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROGNOSIS; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0035380251     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. AYED M., BEN HASSINE L., BEN SLAMA R., CHELBI N., GHOZZI S., DRISSI H., JEMNI M.? CHEBIL M. Résultats du B.C.G. dans le traitement des tumeurs de vessie pTa et pTl. Evaluation d'un protocole long utilisant 75 mg de B.C.G. de source Pasteur. Prog. Urol., 1998, 8, 206-210.
2. CALAIS DA SILVA F., FURTADO L., REIS M., CARREIRA F., DIAS V., OLIVEIRA G. Comparisons of two doses of Interferon α2b in intravesical prophylaxis of superficial bladder tumors. Eur. Urol., 1995, 28, 291-296.
3. CHOPIN D. Les instillations endovésicales dans le traitement des tumeurs superficielles de la vessie. Prog. Urol., 1998, 8, 268-273.
4. FUJII Y., FUKUI I., KIHARA K., TSUJII T., KAGEYAMA Y., OSHIMA H. Late recurence and progression after a long tumor-free period in primary Ta and Tl bladder cancer. Eur. Urol., 1999, 36, 309-313.
5. KOSS L.G. Natural history and patterns of invasive cancer of the bladder. Eur. Urol., 198, 33 (suppl. 4), 2-4.
6. KURTH K.H., DENIS L., BOUFFIOUX C., SYLVESTER R., DEBRUYNE F., PAVONE-MACALUSO M., OOSTERLINCK W. Factors affecting recurence and progression in superficial bladder tumors; Eur. J. Cancer. 1995, 31A, 1840-1846.
7. LACHAND A.T., TEXIER J. Relations entre le carcinome in situ et la papillomatose vésicale. Ann. Urol., 1983, 17, 242-244.
8. LAMM D.L. Preventing progression and improving survival with B.C.G. maintenance. Eur. Urol., 3000, suppl. 1, 9-15.
9. LIUKKONEN T., RAJALA P:, RAITANEN M., RINTALA E., KAASINEN E., LIPPONEN P. PROGNOSIS VALUE OF MIB-1 SCORE, 53, EGFR, MITOTIC INDEX AND PAPILLARY STATUS IN PRIMARY SUPERFICIAL (STAGE TA, Tl) BLADDER CANCER. EUR. UROL., 1999, 36, 393-400.
10. ÖGE Ö., ERDEM E., ATSÜ N., SAHIN A., Özen H. Proposal for changes in cystoscopic follow up of patients with low grade pTa bladder tumors. Eur. Urol., 2000, 37, 271-274.
11. RISCHMANN P., H. BITTARD, D. CHOPIN, P. COLOBY, J.L. DAVIN, J. IRANI, T. LEBRET, M.A. LEFRERE, M. MAIDENBERG, J.M. MARECHAL, J.L. PARIENTE. C. THEORODE. Tumeurs urothéliales. Comité de cancérologie. Recommandations 1998. Prog. Urol., 1998, 8, suppl. 3, 25-31.
12. TOSONI I., WAGNER U., SAUTER G., EGLOF M., KNÖNAGEL H., ALUND G., BANNWART F., MIHATSCH M., GASSER T., MAURER R. Clinical significance of inobervers≫ differences in the staging and grading of superficial bladder cancers. Brit. J. Urol. Int., 2000, 85, 48-53.
13. WRIGHT M., JONES D. Surveillance of bladder cancers. The managment of 4.8 millions people. Brit. J. Urol. Int., 2000, 85. 431-433.
14. ZIEGER K., WOLF H., OLSEN P.R., HOJGAARD K. Long term follow-up of non invasive bladder tumors (stage Ta) : recurences and progression. Brit. J. Urol. Int., 2000, 85, 824-828.
15. ZIEGER K., WOLF H., OLSEN P.R., HOJGAARD K. Long term follow-up of bladder tumors : the significance of risk factors. Brit. J. Urol. Int., 1998, 82, 667-672.